Barclays Lowers Aspen Aerogels (NYSE:ASPN) Price Target to $3.00

Aspen Aerogels (NYSE:ASPN) had its price target reduced by research analysts at Barclays from $4.00 to $3.00 in a research note issued on Thursday,Benzinga reports. The brokerage presently has an “underweight” rating on the construction company’s stock. Barclays‘s target price would suggest a potential downside of 6.83% from the company’s current price.

ASPN has been the topic of a number of other research reports. Weiss Ratings reiterated a “sell (d-)” rating on shares of Aspen Aerogels in a report on Monday, December 29th. Zacks Research upgraded Aspen Aerogels from a “strong sell” rating to a “hold” rating in a research note on Thursday, January 15th. Roth Mkm dropped their target price on Aspen Aerogels from $6.00 to $3.00 and set a “buy” rating on the stock in a research report on Thursday, February 26th. Canaccord Genuity Group cut their price target on Aspen Aerogels from $10.00 to $5.00 and set a “buy” rating on the stock in a research note on Friday, November 7th. Finally, TD Cowen reduced their price target on Aspen Aerogels from $7.00 to $6.00 and set a “buy” rating for the company in a report on Thursday, February 26th. Three investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, Aspen Aerogels currently has a consensus rating of “Hold” and a consensus target price of $4.25.

Aspen Aerogels Stock Performance

Aspen Aerogels stock opened at $3.22 on Thursday. The firm has a market capitalization of $266.13 million, a PE ratio of -0.68 and a beta of 2.99. Aspen Aerogels has a one year low of $2.30 and a one year high of $9.78. The stock’s 50 day moving average price is $3.36 and its 200 day moving average price is $4.91. The company has a debt-to-equity ratio of 0.28, a quick ratio of 3.33 and a current ratio of 3.94.

Aspen Aerogels (NYSE:ASPN) last issued its quarterly earnings data on Wednesday, February 25th. The construction company reported ($0.34) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.27) by ($0.07). Aspen Aerogels had a negative net margin of 143.69% and a negative return on equity of 13.07%. The firm had revenue of $41.34 million during the quarter, compared to analyst estimates of $44.25 million. During the same period last year, the business earned $0.14 EPS. The firm’s revenue was down 66.4% compared to the same quarter last year. Aspen Aerogels has set its Q1 2026 guidance at -0.280–0.240 EPS. As a group, sell-side analysts expect that Aspen Aerogels will post 0.17 EPS for the current fiscal year.

Institutional Investors Weigh In On Aspen Aerogels

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Royal Bank of Canada lifted its position in shares of Aspen Aerogels by 84.7% during the first quarter. Royal Bank of Canada now owns 56,419 shares of the construction company’s stock worth $360,000 after purchasing an additional 25,880 shares during the last quarter. AQR Capital Management LLC acquired a new stake in Aspen Aerogels during the first quarter valued at approximately $960,000. Integrated Wealth Concepts LLC bought a new position in Aspen Aerogels during the 1st quarter worth approximately $84,000. Goldman Sachs Group Inc. lifted its holdings in Aspen Aerogels by 89.7% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,274,356 shares of the construction company’s stock worth $8,143,000 after buying an additional 602,586 shares during the last quarter. Finally, Caxton Associates LLP acquired a new position in shares of Aspen Aerogels in the 1st quarter worth approximately $307,000. Institutional investors own 97.64% of the company’s stock.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.